The Prkralear-5J mice can also be a suitable mouse model for screening potential therapeutic options to alleviate the dystonia symptoms arising from dysregulated eIF2α signaling and should be tested for suitability for such studies. This evidence concerns the gene EIF2A and Dystonia.